293 related articles for article (PubMed ID: 11709782)
21. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
[TBL] [Abstract][Full Text] [Related]
22. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection.
Tresoldi E; Romiti ML; Boniotto M; Crovella S; Salvatori F; Palomba E; Pastore A; Cancrini C; de Martino M; Plebani A; Castelli G; Rossi P; Tovo PA; Amoroso A; Scarlatti G; ;
J Infect Dis; 2002 Mar; 185(5):696-700. PubMed ID: 11865429
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
Hisada M; Lal RB; Masciotra S; Rudolph DL; Martin MP; Carrington M; Wilks RJ; Manns A
J Infect Dis; 2002 May; 185(9):1351-4. PubMed ID: 12001056
[TBL] [Abstract][Full Text] [Related]
25. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
[TBL] [Abstract][Full Text] [Related]
26. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
[TBL] [Abstract][Full Text] [Related]
27. Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.
Brambilla A; Villa C; Rizzardi G; Veglia F; Ghezzi S; Lazzarin A; Cusini M; Muratori S; Santagostino E; Gringeri A; Louie LG; Sheppard HW; Poli G; Michael NL; Pantaleo G; Vicenzi E
J Infect Dis; 2000 Jul; 182(1):311-5. PubMed ID: 10882614
[TBL] [Abstract][Full Text] [Related]
28. CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.
Passam AM; Zafiropoulos A; Miyakis S; Zagoreos I; Stavrianeas NG; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):302-9. PubMed ID: 16286054
[TBL] [Abstract][Full Text] [Related]
29. Summaries for patients. Genes and HIV progression.
Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759637
[No Abstract] [Full Text] [Related]
30. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
[TBL] [Abstract][Full Text] [Related]
31. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
32. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
33. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
Schinkel J; Langendam MW; Coutinho RA; Krol A; Brouwer M; Schuitemaker H
J Infect Dis; 1999 Apr; 179(4):825-31. PubMed ID: 10068577
[TBL] [Abstract][Full Text] [Related]
34. CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.
Vicenzi E; Ghezzi S; Brambilla A; Sheppard HW; Lazzarin A; Poli G; Michael NL
J Infect Dis; 2000 Nov; 182(5):1579-80. PubMed ID: 11023492
[No Abstract] [Full Text] [Related]
35. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
36. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
[TBL] [Abstract][Full Text] [Related]
37. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA; Kang S; Koup RA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
[TBL] [Abstract][Full Text] [Related]
39. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
[TBL] [Abstract][Full Text] [Related]
40. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.
Ramana GV; Vasanthi A; Khaja M; Su B; Govindaiah V; Jin L; Singh L; Chakraborty R
J Genet; 2001 Dec; 80(3):137-40. PubMed ID: 11988632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
